Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Other
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseOtherC57Bl/6n = Initial series of 17 transplants; mitomycin C-treated delay…Intraneural injection by glass micropipette into the transected distal tibial nerveTen thousand differentiated cells per transplant; mitomycin…Immediately after transection or after a delay of 1, 2, 4 or 8 weeks
Model: Tibial nerve transection at midthigh with ligation of both ends and burial of the proximal stump, producing prolonged denervation of the medial gastrocnemius
Mitomycin C pretreatment eliminated the residual pluripotent population and abolished teratocarcinoma formation (0 of 20 animals) while preserving motoneurons, giving twitch and tetanic forces after 1 to 4 week delayed transplantation similar to immediate transplantation of untreated cells, with no…
Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.